AU1395383A - Benzoazacycloalkyl-spiro-imidazolidines - Google Patents

Benzoazacycloalkyl-spiro-imidazolidines

Info

Publication number
AU1395383A
AU1395383A AU13953/83A AU1395383A AU1395383A AU 1395383 A AU1395383 A AU 1395383A AU 13953/83 A AU13953/83 A AU 13953/83A AU 1395383 A AU1395383 A AU 1395383A AU 1395383 A AU1395383 A AU 1395383A
Authority
AU
Australia
Prior art keywords
benzoazacycloalkyl
imidazolidines
spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13953/83A
Other languages
English (en)
Inventor
Michelle Boulanger
Jacques Duhault
Charles Malen
Jean-Louis Peglion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of AU1395383A publication Critical patent/AU1395383A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
AU13953/83A 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines Abandoned AU1395383A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
FR8207203 1982-04-27

Publications (1)

Publication Number Publication Date
AU1395383A true AU1395383A (en) 1983-11-03

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13953/83A Abandoned AU1395383A (en) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines

Country Status (22)

Country Link
JP (1) JPS5910584A (el)
KR (1) KR840004428A (el)
AT (1) ATA125383A (el)
AU (1) AU1395383A (el)
BE (1) BE896572A (el)
DD (1) DD209833A5 (el)
DE (1) DE3315106A1 (el)
DK (1) DK183583A (el)
ES (1) ES8405796A1 (el)
FR (1) FR2525603A1 (el)
GB (1) GB2133401B (el)
GR (1) GR78481B (el)
IL (1) IL68497A0 (el)
IT (1) IT1167123B (el)
LU (1) LU84770A1 (el)
MA (1) MA19783A1 (el)
NL (1) NL8301476A (el)
NO (1) NO831473L (el)
OA (1) OA07412A (el)
PT (1) PT76595B (el)
SE (1) SE8302347L (el)
ZA (1) ZA832927B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EA016558B1 (ru) 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором
HUE028976T2 (en) 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
JP5270167B2 (ja) 2004-12-21 2013-08-21 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンザゼピン塩酸塩の結晶形
CN102631349A (zh) 2004-12-23 2012-08-15 艾尼纳制药公司 5HT2c受体调节剂组合物和使用方法
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
EP2611433A2 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
KR20150070249A (ko) 2012-10-09 2015-06-24 아레나 파마슈티칼스, 인크. 체중 관리 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
FR2525603A1 (fr) 1983-10-28
BE896572A (fr) 1983-10-26
DK183583A (da) 1983-10-28
IT8348155A0 (it) 1983-04-26
DK183583D0 (da) 1983-04-26
JPS5910584A (ja) 1984-01-20
NL8301476A (nl) 1983-11-16
KR840004428A (ko) 1984-10-15
NO831473L (no) 1983-10-28
MA19783A1 (fr) 1983-12-31
GB8311508D0 (en) 1983-06-02
ES521895A0 (es) 1984-06-16
DD209833A5 (de) 1984-05-23
DE3315106A1 (de) 1983-11-03
IT1167123B (it) 1987-05-13
ZA832927B (en) 1984-06-27
GR78481B (el) 1984-09-27
LU84770A1 (fr) 1984-11-28
ES8405796A1 (es) 1984-06-16
GB2133401B (en) 1985-10-23
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
PT76595B (fr) 1986-01-21
IL68497A0 (en) 1983-07-31
ATA125383A (de) 1986-05-15
GB2133401A (en) 1984-07-25
SE8302347L (sv) 1983-10-28
FR2525603B1 (el) 1984-09-14
OA07412A (fr) 1984-11-30

Similar Documents

Publication Publication Date Title
AU1146383A (en) Amidoximeguinolines
AU1383083A (en) Ligator-clip
AU1761783A (en) Photoradiator
AU1115783A (en) Quadricycle
AU1491183A (en) Curler-styler
AU1659483A (en) 14-fluoromorphinans
AU1112583A (en) Pyrazolo-quinolines, -thiazines and -oxazines
AU1649683A (en) 1-dethia-1-oxa-3-cephem-derivatives
AU1315083A (en) Massage-douche
AU1708883A (en) Ratschenartiger maulschlussel
AU1557383A (en) Hestesko
AU1602483A (en) Sectionaliser
AU1475883A (en) Dosierpumpe
AU1395383A (en) Benzoazacycloalkyl-spiro-imidazolidines
AU1227483A (en) Klaranlage
AU1636583A (en) 19-thio-androstanes
AU1476983A (en) Bomanordning
AU1704883A (en) Pferdehufschuh
AU1471483A (en) Tallerkenknuser
AU1824183A (en) Schneckenpresse
AU1553583A (en) Arbeitsmaschine
AU1674883A (en) Interferon-epsilon
AU1089783A (en) N-benzothienylalkyl-n-alkyl-allylamines
AU1734083A (en) Trans-1-n-propyl-6-oxodecahydroquinoline
AU1222883A (en) Transmissionsmekanisme